Figure S7. (A) Two-way unsupervised hierarchical clustering of RPPA data of 2 G1, 7 G2, 8 G3, and 3 G4 ccRCC populations for the expression of stem cell markers reported as heatmap. (B) mRNA expression of SOX2 gene in G2, G3, and G4 ccRCC samples as assessed by RT-qPCR. Mean of three independent experiments is reported. RRN18S was used as endogenous control. *p < 0.05 (C) Representative immunofluorescence staining of tumor derived spheroids showing positivity for SOX2 (red). Merge is the over-lapping of SOX2 and DAPI staining. Confocal-microscope used Olympus, Fluoview FV1000 (Tokyo, Japan, http://www.olympus-global.com), magnification 40X. (PDF 246 kb
Table S4. Clinical features of 30 collected ccRCC patients and used for in vivo models including: 3 ...
Overexpression of NEDD9 restores the oncogenic properties of SOX10 KD + SOX9 KD melanoma cells. (A) ...
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...
Figure S10. (A) Kaplan-Meier curve for the Disease Free Survival (DFS) in the engrafted (Engraf) and...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Figure S3 (A) RPPA-TCGA elaboration of E-Cadherin and Fibronectin expressions. Data were obtained fr...
Figure S2. (A) Hematoxylin and Eosin (H&E) and CD31 staining of formalin-fixed and paraffin- embedde...
Figure S6. (A) Freshly dissociated tissues maintained for one week in serum-free stem cell-isolating...
Figure S1. (A) (PANEL1) Table of 1286 ccRCC patient distribution: 1013 tumor free patients at 36 mon...
Figure S4. (A) Fresh dissociated tissues maintained for three days in serum-free stem cell-isolating...
Table S2. Clinical features of 20 collected ccRCC patients including: 2 G1; 7 G2; 8 G3 and 3 G4 proc...
Figure S5. Freshly dissociated tissues were maintained three days in serum-free stem cell-isolating ...
Activity of druggable pathways of pRCC and mRCC cells in the PCA plot. The plots show heterogeneous ...
Supplement S2. (a) The fusion types of three renal carcinoma cell lines were detected by PCR. (b, c)...
Figure S9. Hematoxylin and Eosin staining of PDXs versus parental primary tumor. G4 tumors often ret...
Table S4. Clinical features of 30 collected ccRCC patients and used for in vivo models including: 3 ...
Overexpression of NEDD9 restores the oncogenic properties of SOX10 KD + SOX9 KD melanoma cells. (A) ...
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...
Figure S10. (A) Kaplan-Meier curve for the Disease Free Survival (DFS) in the engrafted (Engraf) and...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Figure S3 (A) RPPA-TCGA elaboration of E-Cadherin and Fibronectin expressions. Data were obtained fr...
Figure S2. (A) Hematoxylin and Eosin (H&E) and CD31 staining of formalin-fixed and paraffin- embedde...
Figure S6. (A) Freshly dissociated tissues maintained for one week in serum-free stem cell-isolating...
Figure S1. (A) (PANEL1) Table of 1286 ccRCC patient distribution: 1013 tumor free patients at 36 mon...
Figure S4. (A) Fresh dissociated tissues maintained for three days in serum-free stem cell-isolating...
Table S2. Clinical features of 20 collected ccRCC patients including: 2 G1; 7 G2; 8 G3 and 3 G4 proc...
Figure S5. Freshly dissociated tissues were maintained three days in serum-free stem cell-isolating ...
Activity of druggable pathways of pRCC and mRCC cells in the PCA plot. The plots show heterogeneous ...
Supplement S2. (a) The fusion types of three renal carcinoma cell lines were detected by PCR. (b, c)...
Figure S9. Hematoxylin and Eosin staining of PDXs versus parental primary tumor. G4 tumors often ret...
Table S4. Clinical features of 30 collected ccRCC patients and used for in vivo models including: 3 ...
Overexpression of NEDD9 restores the oncogenic properties of SOX10 KD + SOX9 KD melanoma cells. (A) ...
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...